文献速递痛风与晶体性关节病

全基因组关联研究揭示无症状高尿酸血症进展为痛风的新基因位点

Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.
PubMed 文献 · Ann Rheum Dis · 2019-07-08

该研究首次以临床确诊痛风患者与无症状高尿酸血症(AHUA)对照进行全基因组关联研究(GWAS),共分析2860例痛风患者和3149例AHUA对照(均为日本男性)。研究识别出CNTN5和MIR302F两个新痛风位点及ZNF724提示性位点,并首次通过GWAS确认ALDH2 rs671为痛风位点,提示这些位点与晶体诱导炎症机制相关,有别于已知主要升高血尿酸水平的风险位点。

要点

  • 首次以痛风 vs AHUA 对照的 GWAS 识别出 CNTN5、MIR302F 新位点及 ZNF724 提示性位点。
  • ALDH2 rs671 首次被 GWAS 确认为痛风位点,ABCG2 和 SLC2A9 位点亦被识别。
  • CNTN5、MIR302F、ZNF724 与晶体诱导炎症机制相关,不同于主要升高血尿酸水平的已知位点。

核心结论

  • 首次揭示与晶体诱导炎症相关的基因位点,该过程是 AHUA 进展为痛风的最后一步,有助于阐明痛风发病分子机制并辅助高危 AHUA 个体的痛风发作预防。

研究设计与样本

  • 对945例临床确诊痛风病例和1003例AHUA对照进行GWAS,并进行2项复制研究,共分析2860例痛风病例和3149例AHUA对照(均为日本男性)。

主要发现

  • 识别出两个新痛风位点:CNTN5的rs7927466和MIR302F的rs9952962,以及一个提示性位点ZNF724的rs12980365,均达到全基因组显著性水平(p<5.0×10-8)。
  • 还识别出ABCG2、ALDH2和SLC2A9位点,其中ALDH2的rs671首次通过GWAS被确认为痛风位点。
  • 比较本次GWAS与既往GWAS(痛风 vs 正常尿酸血症)各 locus 的 OR 值,发现CNTN5、MIR302F和ZNF724三个位点为「痛风 vs AHUA GWAS」特异性位点,与主要升高血尿酸水平的已知痛风风险位点的机制明显不同。

关键数值与推荐

  • 全基因组显著性定义为p<5.0×10-8。
  • 共分析2860例痛风病例和3149例AHUA对照(均为日本男性)。

临床怎么用

  • 对于无症状高尿酸血症个体,可关注CNTN5、MIR302F、ZNF724等与晶体诱导炎症相关的位点,以评估痛风发作风险并辅助预防。

局限性

  • 研究人群仅限日本男性,结论外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The first ever genome-wide association study (GWAS) of clinically defined gout cases and asymptomatic hyperuricaemia (AHUA) controls was performed to identify novel gout loci that aggravate AHUA into gout. METHODS: We carried out a GWAS of 945 clinically defined gout cases and 1003 AHUA controls followed by 2 replication studies. In total, 2860 gout cases and 3149 AHUA controls (all Japanese men) were analysed. We also compared the ORs for each locus in the present GWAS (gout vs AHUA) with those in the previous GWAS (gout vs normouricaemia). RESULTS: This new approach enabled us to identify two novel gout loci (rs7927466 of CNTN5 and rs9952962 of MIR302F) and one suggestive locus (rs12980365 of ZNF724) at the genome-wide significance level (p<5.0×10-8). The present study also identified the loci of ABCG2, ALDH2 and SLC2A9. One of them, rs671 of ALDH2, was identified as a gout locus by GWAS for the first time. Comparing ORs for each locus in the present versus the previous GWAS revealed three 'gout vs AHUA GWAS'-specific loci (CNTN5, MIR302F and ZNF724) to be clearly associated with mechanisms of gout development which distinctly differ from the known gout risk loci that basically elevate serum uric acid level. CONCLUSIONS: This meta-analysis is the first to reveal the loci associated with crystal-induced inflammation, the last step in gout development that aggravates AHUA into gout. Our findings should help to elucidate the molecular mechanisms of gout development and assist the prevention of gout attacks in high-risk AHUA individuals.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kawamura Y, Nakaoka H, Nakayama A, et al. Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout. Ann Rheum Dis. 2019. PMID: 31289104. doi:10.1136/annrheumdis-2019-215521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。